Juvenescence Ltd
CIK 1724307 · last filed 2025-02-03
Juvenescence Ltd is a corporate insider who has filed 20 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for SER, was dated Feb 3, 2025. Current disclosed insider exposure totals $5.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$5.09M
2
20
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SER | 10%+ Owner | 2,767,188 | $1.84 | $5.09M | $0 | 1 | 2025-02-03 |
| Serina Therapeutics, Inc. (AGE) Delisted | Director | 16,447,500 | $11.10 | $182.57M | $0 | 19 | 2023-05-18 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-03 | SER | Mixed | +1,377,865 | $14.99M | EDGAR |
| 2023-05-18 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-03-22 | Serina Therapeutics, Inc. (AGE) Delisted | Gift (G) | −16,447,500 | $0 | EDGAR |
| 2023-02-17 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-08 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-19 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-10-27 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-24 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-24 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-14 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |